Noticias | ICU Medical

Product Announcements and Company News

Manténgase al día sobre las noticias más recientes de Smiths Medical, lo que incluye anuncios de productos, noticias y promociones.

Para obtener más información, póngase en contacto con nosotros. Contacto para los medios.

Productos para la seguridad para agujas y objetos punzantes
Worldwide Notification Regarding the Recall of Jelco^® Hypodermic Needle-Pro^® Fixed Needle Insulin Syringe with Skewed Graduation Markings
Smiths Medical has become aware of specific models and lots of Jelco^® Hypodermic Needle-Pro^® Fixed Needle Insulin Syringes that may exhibit skewed odd number line graduation markings on their syringe barrels.
17/06/2021
Ver más
Productos de infusión
Smiths Medical and Ivenix Partner to Revolutionize Infusion Management with First-Ever Comprehensive Suite of Infusion Solutions in US Healthcare Market
Smiths Medical, a global medical device leader, today announced it has formed an exclusive partnership with Ivenix, Inc. that positions the companies as the first in the U.S. to offer a comprehensive suite of infusion management solutions to meet healthcare needs across the continuum of care.
4/05/2021
Ver más
Productos respiratorios
Introducing the Portex^® Acapella^® Choice Blue Vibratory Positive Expiratory Pressure (PEP) Therapy System
Smiths Medical announces the launch of the acapella^® choice blue vibratory PEP therapy system. Acapella^® is designed to aid in the removal of secretions for patients who have Cystic Fibrosis, Chronic Obstructive Pulmonary Disease (COPD), asthma, lung disease with secretory problems, and patients with atelectasis.
28/04/2021
Ver más
Productos de infusión
Smiths Medical partners with Parkview Health to enhance patient and clinician safety
Parkview Health’s integration of the Smiths Medical PharmGuard® Infusion Management System enables smart pump programming and auto documentation to improve safety.
14/04/2021
Ver más
Productos de infusión
ECRI Evaluation of CADD^®-Solis V4 Wireless Ambulatory Infusion System
The report highlights ECRI’s evaluation ratings, test results, and purchasing recommendations for the CADD®-Solis pump.
30/03/2021
Ver más
Productos para el tratamiento del dolor
Launch of Portex^® EchoGlo^® Peripheral Nerve Block Portfolio
Smiths Medical, a leading medical device manufacturer, is excited to announce the launch of its EchoGlo^® peripheral nerve block portfolio. This addition to the Portex^® portfolio of pain management products offers customers a complete solution for regional anesthesia from pump to patient.
14/12/2020
Ver más
Productos de infusión
CADD^®-Solis Wireless Communication - Cybersecurity Bulletin
Smiths Medical is aware of, and currently monitoring, the Cybersecurity and Infrastructure Security Agency (CISA) notification concerning the Cybersecurity Vulnerability, ICSA-20-168-011 (the “Advisory”).
20/11/2020
Ver más
Productos de infusión
Worldwide Notification Regarding Potential for Inappropriate Bolus or Loading Dose Delivery in Certain Medfusion^® 3500 and 4000 Infusion Pumps
Due to a software error, if a bolus or loading dose is interrupted and a specific sequence of events occurs, over- or under-delivery of a bolus or loading dose may occur.
19/08/2020
Ver más
Productos para la seguridad para agujas y objetos punzantes
Smiths Medical partners with U.S. government on COVID-19 vaccine efforts
The partnership with BARDA and JPEO-CBRND includes a $20 million investment for increased syringe and needle device production to support Operation Warp Speed vaccine program.
15/07/2020
Ver más
Productos de infusión
Smiths Medical Cybersecurity Bulletin
Smiths Medical is aware of, and currently monitoring, the Cybersecurity and Infrastructure Security Agency (CISA) notification concerning the Cybersecurity Vulnerability, ICSA-20-168-01
2/07/2020
Ver más
Catéteres intravenosos periféricos (PIVC)
Smiths Medical Acquires Access Scientific
Smiths Medical acquires the business of Access Scientific, LLC, expanding vascular access offering.
13/05/2020
Ver más
Productos de infusión
No Smiths Medical products affected by FDA and CISA "URGENT/11" vulnerabilities
The FDA and CISA announced a set of cybersecurity vulnerabilities referred to as "URGENT/11" that have the potential to introduce risks to certain medical devices or hospital networks.
16/10/2019
Ver más

PreviousNext